Nanotechnology: Its Application in Treating Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Biotechnology
• Materials Science

Background:

• Neurodegenerative diseases (Alzheimer's, Parkinson's, Huntington's) significantly impair quality of life.
• Current diagnostic and treatment methods for these diseases have limitations.
• A major challenge is the inability of many treatments to cross the blood-brain barrier (BBB).

Purpose of the Study:

• To review the application of nanotechnology in treating neurodegenerative diseases over the past two decades.
• To highlight how nanotechnology can address limitations in current therapeutic strategies.
• To explore the potential of nanomedicine in overcoming the BBB for neurological disorders.

Main Methods:

• Comprehensive literature review of studies published in the last 20 years.
• Focus on research involving nanotechnology for neurodegenerative disease treatment.
• Analysis of strategies aimed at enhancing drug delivery across the BBB.

Main Results:

• Nanotechnology presents promising solutions for neurodegenerative disease treatment.
• Various nanomaterials and nanocarriers have been investigated for targeted drug delivery.
• Significant progress has been made in developing nanotechnologies capable of crossing the BBB.

Conclusions:

• Nanotechnology holds considerable potential to revolutionize the treatment of neurodegenerative diseases.
• Overcoming the BBB remains a key focus for nanomedical interventions.
• Continued research in nanomedicine is crucial for developing effective therapies for Alzheimer's, Parkinson's, and Huntington's disease.